Menu
Our mission is to develop a cure for the 50% of schoolchildren who currently suffer from one or more allergies
Glyco-immunology is an emerging scientific field that is rapidly evolving.
GlycoTreat’s scientific co-founder, Prof. Yvette van Kooyk, Molecular Cell Biology and Immunology at Amsterdam UMC, was awarded the 2019 Spinoza Prize for her groundbreaking research discovering that specific complex sugar chains can modify the immune system by suppressing or activating the immune response.
Utilizing this unique glycan-mediated immune pathway, redirecting the immune system to develop tolerance towards specific antigens, GlycoTreat is now at the forefront of bringing a whole new generation of short-term Allergen ImmunoTherapy to the clinic.
Our mission is to develop a cure for the more than 50% of school children that suffer from one or more allergies.
Technological advances have revealed the vital role played by cell surface glycans in regulating the immune response.
GlycoTreat has discovered how these structures can be manipulated to suppress the immune system and treat allergic diseases.
Prof. Yvette van Kooyk received the Spinoza Prize in 2019 for her groundbreaking research in the field of glyco-immunology.
The Spinoza Prize is the most prestigious award in Dutch academia.
She has unraveled the way in which the immune system becomes dysregulated in the development of cancer, autoimmune diseases, and infectious diseases such as HIV/AIDS. She discovered that certain sugar molecules, called glycans, can stimulate or inhibit communication between cells of the immune system. Prof. Yvette van Kooyk developed nano-medicines that support the immune system in the fight against cancer, autoimmune diseases, allergies and infectious diseases, and is considered a world expert in this field.
Ina Margaretha Rijnhout
our glyco-immunology platform will change the change the life of millions of patients suffering from allergies, providing a short curative treatment, promoting a healthy and high quality of life
Yvette van Kooyk
our new and disruptive glycan-based immunomodulating approach addresses the need for faster and more durable allergy treatment
GlycoTreat BV.
Koningin Beatrixplantsoen 28
3818 ZB Amersfoort
The Netherlands
